Villepinte, France, December 17 (8 a.m. CET) - Guerbet (FR0000032526 GBT), a world leader in medical imaging, received an A- rating for its second participation in the CDP Climate Questionnaire, a non-profit organization that distinguishes the world's most active companies in the fight against climate change, improving its score from last year (B).

The CDP's annual environmental performance reporting and rating process is a benchmark for corporate environmental transparency. In 2020, more than 515 investors with assets of more than $106 trillion and more than 150 acquirers with $4 trillion in assets called on organizations to share their environmental impact and opportunities and risks and opportunities through the CDP platform.

"As we celebrate the fifth anniversary of the Paris Agreement, we are very pleased that our commitment and progress is being recognized by the CDP. Guerbet continues its dynamic CSR approach, a real lever of performance and a differentiator, under the historical impetus of family shareholders. We are committed to reducing our environmental footprint and engaging our ecosystem in a virtuous circle of decarbonization," comments Petra Zalabak, Guerbet's Director of Human Resources and CSR.

Guerbet's CSR approach is based on four axes with key objectives and actions by 2023. One of the main areas is the HSE policy, which gives top priority to the safety of people and also aims to minimize environmental impacts at all levels.

Through its HSE policy, Guerbet is committed to implementing solutions aimed at preserving the environment through the performance of industrial facilities and actions aimed at limiting their environmental impacts:

  • Mastery of production processes;
  • Sustainable use of natural resources;
  • Fighting climate change;
  • Process innovation approach;
  • Control of releases.

Guerbet is also committed to implementing actions to reduce its impact on global warming.

On its key programming positions, the Group:

  • Strengthens the HSE and CSR continuous improvement approach with the most at-risk suppliers;
  • Prefers shipping over air travel when sending its finished products to its customers;
  • Reduces energy consumption at all its industrial sites.

[1] CDP: Carbon Disclosure Project. Disclosure Insight Action.

About Guerbet

Guerbet is a global medical imaging leader, offering a wide range of pharmaceuticals, medical devices, digital solutions and AI, for diagnostic and interventional imaging, to improve patient care. A pioneer for more than 90 years in the field of contrast products, with more than 2,800 employees worldwide, Guerbet continuously innovates and devotes 9% of its sales to Research and Development in four centers in France, Israel and the United States. Guerbet (GBT) is listed in Euronext Paris' B compartment and has a turnover of 817 million euros in 2019. For more information about Guerbet, please visit www.guerbet-us.com